Niboshi Ayumi, Nishida Masashi, Itoi Toshiyuki, Shiraishi Isao, Hamaoka Kenji
Department of Pediatric Cardiology and Nephrology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kawaramachi-Hirokoji, Kamikyo-ku Kyoto, Japan.
Indian J Pediatr. 2006 Jan;73(1):49-53. doi: 10.1007/BF02758260.
To study the effect of non-ionic contrast medium on renal function in children with cardiovascular disease.
Analysis of renal function in 98 children with cardiovascular disease before and after the use of Iopamidol, Iohexol, and Ioversol was done for angiography. Serum creatinine (s-Cre), urinary N-acetyl-beta-D-glucosaminase (u-NAG), urinary beta 2-microglobulin (u-BMG), and urinary alpha 1-microglobulin (u-AMG) levels were evaluated.
Although s-Cre levels remained unchanged, u-NAG/Cre, u-AMG/Cre and u-BMG/Cre significantly increased 12 hours after angiography. Levels of u-NAG/Cre, u-BMG/Cre, and u-AMG/Cre after angiography were significantly higher in neonates and infants (age< 12-months, n=32) than in children (age>1-year, n=61), in patients with more than 5 ml/kg of contrast medium (n=25) than in those with less than 5 ml/kg (n=70) and in cyanotic patients (n=13) than in non-cyanotic (n=80) patients.
Transient renal tubular dysfunction occurred in all of these three non-ionic contrast mediums. Although renal tubular function was intact on a long-term basis, one should be careful of contrast medium-induced nephropathy, especially in neonates and infants, in patients receiving more than 5 ml/kg of contrast mediums in total, and in patients with cyanotic heart disease in using non-ionic contrast mediums.
研究非离子型造影剂对心血管疾病患儿肾功能的影响。
对98例心血管疾病患儿在使用碘帕醇、碘海醇和碘佛醇进行血管造影前后的肾功能进行分析。评估血清肌酐(s-Cre)、尿N-乙酰-β-D-氨基葡萄糖苷酶(u-NAG)、尿β2-微球蛋白(u-BMG)和尿α1-微球蛋白(u-AMG)水平。
尽管s-Cre水平保持不变,但血管造影后12小时u-NAG/Cre、u-AMG/Cre和u-BMG/Cre显著升高。血管造影后,新生儿和婴儿(年龄<12个月,n = 32)的u-NAG/Cre、u-BMG/Cre和u-AMG/Cre水平显著高于儿童(年龄>1岁,n = 61),使用造影剂超过5 ml/kg的患者(n = 25)高于使用造影剂少于5 ml/kg的患者(n = 70),青紫型患者(n = 13)高于非青紫型患者(n = 80)。
这三种非离子型造影剂均会导致短暂性肾小管功能障碍。尽管肾小管功能长期保持完好,但在使用非离子型造影剂时,应注意造影剂诱发的肾病,尤其是在新生儿和婴儿、造影剂总量超过5 ml/kg的患者以及青紫型心脏病患者中。